Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Autografting

Patients mobilizing large numbers of CD34+ cells (‘super mobilizers’) have improved survival in autologous stem cell transplantation for lymphoid malignancies

Bone Marrow Transplantation volume 40, pages 437–441 (2007)Cite this article

Abstract

The cellular composition of an autologous graft may influence autologous stem cell transplantation (ASCT) outcome. Etoposide (VP) plus filgrastim (G) frequently mobilizes high numbers of CD34+ cells for autologous transplantation. We investigated whether patients collecting high numbers of CD34+ cells (‘super mobilizers’) have a better outcome than other patients. We reviewed 350 consecutive adult patients with NHL or Hodgkin's lymphoma receiving an ASCT from January 1994 to December 2005, mobilized with VP+G. Super mobilizers were defined as collecting a minimum of 8 × 106 CD34+ cells/kg. Two hundred and three patients were super mobilizers, while 147 collected between 2.0 and 7.95 CD34+ cells/kg. Super mobilizers were younger and more likely to have received two or fewer prior chemotherapy regimens (80 versus 63%, P<0.001). Median CD34+ cell dose for the super mobilizing group was 13.7 × 106 versus 4.4 × 106/kg in the standard collecting group. The super mobilizer group had a superior overall survival (P=0.006). In multivariable analysis, favorable disease status and younger age at transplant, and super mobilization were associated with improved survival. We conclude that patients had an improved ASCT outcome if large numbers of CD34+ cells were mobilized and infused. The explanation for this observation is unknown.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Bolwell BJ . Are predictive factors clinically useful in bone marrow transplantation? Bone Marrow Transplant 2003; 32: 853–861.

    Article  CAS  Google Scholar 

  2. Copelan EA . Hematopoietic stem cell transplantation. New Engl J Med 2006; 354: 1813–1826.

    Article  CAS  Google Scholar 

  3. Bolwell BJ . Factors predicting success or failure associated with common types of transplants. Pediatr Transplant 2005; 9: 2–11.

    Article  Google Scholar 

  4. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan K et al. Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Exp Hematol 2004; 32: 397–407.

    Article  CAS  Google Scholar 

  5. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23: 5074–5087.

    Article  PubMed Central  Google Scholar 

  6. Porrata LF, Litzow MR, Inwards DJ, Gastineau DA, Moore SB, Pineda AA et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant 2004; 33: 291–298.

    Article  CAS  Google Scholar 

  7. Dean R, Masci P, Pohlman B, Andresen S, Serafino S, Sobecks R et al. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Bone Marrow Transplant 2005; 36: 1049–1052.

    Article  CAS  Google Scholar 

  8. Copelan EA, Ceselski SK, Ezzone SA, Lasky LC, Panza SL, Bechtel TP et al. Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease. J Clin Oncol 1997; 15: 759–765.

    Article  CAS  Google Scholar 

  9. Kanfer EJ, McGuigan D, Samson D, Abboudi Z, Abrahamson G, Apperley JF et al. High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels. Br J Cancer 1998; 78: 928–932.

    Article  CAS  PubMed Central  Google Scholar 

  10. Bolwell BJ, Goormastic M, Yanssens T, Dannley R, Baucco P, Fishleder A . Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 1994; 14: 913–918.

    CAS  PubMed  Google Scholar 

  11. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C . Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy. J Clin Oncol 2000; 18: 1360–1377.

    Article  CAS  Google Scholar 

  12. Boeve S, Strupeck J, Creech S, Stiff PJ . Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost. Bone Marrow Transplant 2004; 33: 997–1003.

    Article  CAS  Google Scholar 

  13. Ford CD, Green W, Warenski S, Petersen FB . Effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplant 2004; 33: 901–905.

    Article  CAS  Google Scholar 

  14. Copelan E, Hoshaw-Woodard S, Elder P, Penza S, Farag S et al. Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation. Bone Marrow Transplant 2004; 34: 85–87.

    Article  CAS  Google Scholar 

  15. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005; 201: 1307–1318.

    Article  CAS  PubMed Central  Google Scholar 

  16. Devine SM, Flomenberg N, Vesole DF, Liesveld J, Weisdorf D, Badel K et al. Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J Clin Oncol 2004; 22: 1095–1102.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH, USA

    B J Bolwell, B Pohlman, R Sobecks, R Dean, J Curtis, S Andresen, A Koo, V Mineff, M Kalaycio & J W Sweetenham

  2. Department of Quantitative Health Sciences, Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH, USA

    L Rybicki

Authors
  1. B J Bolwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Pohlman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Rybicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Sobecks
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Dean
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Curtis
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S Andresen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Koo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. V Mineff
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M Kalaycio
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J W Sweetenham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B J Bolwell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolwell, B., Pohlman, B., Rybicki, L. et al. Patients mobilizing large numbers of CD34+ cells (‘super mobilizers’) have improved survival in autologous stem cell transplantation for lymphoid malignancies. Bone Marrow Transplant 40, 437–441 (2007). https://doi.org/10.1038/sj.bmt.1705763

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705763

Keywords

This article is cited by

Search

Advanced search

Quick links